Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse BDNF ELISA Kit (AC3892)
Cat.#: ASET-2481
Specifications
Description Mouse BDNF ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse BDNF concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.021 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.4-6.4 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1654 Rat CDK5 ELISA Kit (AC3065) Quantitative inquiry ASET-1407 Human BMAL1 ELISA Kit (AC2818) Quantitative inquiry ASET-1709 Canine alpha Synuclein ELISA Kit (AC3120) Quantitative inquiry ASET-1057 Human COMT ELISA Kit (AC2468) Quantitative inquiry ASET-2368 Human Somatostatin ELISA Kit (AC3779) Quantitative inquiry ASET-2107 Rat Slit2 ELISA Kit (AC3518) Quantitative inquiry ASET-2520 Rat MMP24 ELISA Kit (AC3931) Quantitative inquiry ASET-1625 Human TDP43 ELISA Kit (AC3036) Quantitative inquiry ASET-1349 Monkey Luteinizing Hormone ELISA Kit (AC2760) Quantitative inquiry ASET-1137 Rat SOX9 ELISA Kit (AC2548) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket